Skip to main content
Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.480
+0.060 (4.23%)
At close: Apr 28, 2026, 4:00 PM EDT
1.500
+0.020 (1.35%)
Pre-market: Apr 29, 2026, 4:01 AM EDT

Autolus Therapeutics Employees

As of December 31, 2025, Autolus Therapeutics had 754 total employees, including 752 full-time and 2 part-time employees. The number of employees increased by 104 or 16.00% compared to the previous year.

Employees
754
Change (1Y)
104
Growth (1Y)
16.00%
Revenue / Employee
$99,984
Profits / Employee
-$381,337
Market Cap
393.89M

Employees Chart

Employees History

Date Employees Change Growth
Dec 31, 202575410416.00%
Dec 31, 202465017938.00%
Dec 31, 20234716716.58%
Dec 31, 20224047723.55%
Dec 31, 2021327-57-14.84%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Sep 30, 2018 Pro Pro Pro
Sep 30, 2017 Pro Pro Pro
Sep 30, 2016 Pro Pro Pro

Related Stocks

Company Name Employees
Vanda Pharmaceuticals 533
Rocket Pharmaceuticals 202
Puma Biotechnology 179
Invivyd 122
Enanta Pharmaceuticals 120
Niagen Bioscience 117
Neumora Therapeutics 96
Century Therapeutics 78
Employee Rankings

AUTL News

More News